One of the first inquiries from most patients and their families following diagnosis is whether they will permanently overcome the disorder. An accurate response depends heavily on the specifics of the disease involved, the patient's age at onset, the etiologic process, and the efficacy of treatment. Some patients achieve resolution, either spontaneously due to age or through successful surgery, whereas others deal with the condition throughout their lifetime.
The term cure has a clear denotation in most health contexts: the permanent elimination of a particular condition. However, in the case of epilepsy, the use of language is much more subtle. Doctors differentiate among seizure-free, remission, and cure. Seizure-free means that no seizures occur, but this might be due to the influence of medication. Remission means that a person has not had seizures for a long time, possibly without using medication.
There are many types of childhood-onset epilepsy syndromes whose medical literature agrees will remit with age. Children diagnosed with these types of syndromes often achieve long-term remission, and in some instances, they may never receive medication.It is estimated that childhood absence epilepsy will remit in about 70 per cent of children by the time they reach mid-adolescence. On the other hand, benign childhood epilepsy with centrotemporal spikes is considered to remit in virtually all patients by age 16. Panayiotopoulos syndrome is generally expected to remit within one to two years of its onset.Overall, these syndromes serve as important reminders that having epilepsy in childhood does not guarantee that a patient will have it in adult life. Therefore, parents should be given accurate information regarding the prognosis from the very beginning.
However, there are some syndromes of epilepsy that remain present throughout the lifespan requiring continuous treatment after each spell to help maintain seizure control. An important one is Juvenile myoclonic epilepsy. Even though the condition is responsive to treatment, its relapse rate is over 90% in many series meaning that seizure freedom can be achieved, but this is not a true remission from the disease itself.Condition such as Dravet syndrome, Lennox-Gastaut syndrome, and epilepsies related to structural brain injury or genetic mutations in ion channels also belong to the set of chronic condition where the goal of treatment is long–term management benefits rather than curing the condition.
According to the document titled Gaining Insights into Seizure Disorders, it can be concluded that individuals undergoing treatment for medicine-resistant focal epilepsy have the highest chances of benefiting from surgical procedures and possibly achieving the outcome of complete recovery. As for people with mesial temporal sclerosis indicated by MRI, temporal lobe surgery ensures the achievement of long-term seizure-free state for about 60-70% of such patients. In case patients remain seizure-free for more than five years following the surgery, the medicines aimed at preventing seizures are usually gradually stopped, and many patients continue their seizure-free living indefinitely since this can be considered a genuine cure in the sphere of epilepsy.
Epilepsy-related inquiries about prognosis should be referred to Neurology since a thorough evaluation via continuous video-EEG monitoring, MRI, neuropsychological evaluation, and proper epilepsy syndrome classification must be conducted to provide accurate diagnosis and treatment. The neurologist/epileptologist is competent to decide on possible resolution of the epilepsy syndrome, need for a surgical evaluation procedure, and possible withdrawal from treatment after establishment of a certain seizure-free period as needed.
Patients whose epilepsy does not warrant surgical treatment or are not suitable for surgical treatment still use antiseizure medications as their primary means of achieving a seizure-free state during the time they are seeking or maintaining remission.Levetiracetam is one of the most popular antiseizure medications in the world. It works through a novel mechanism by acting on synaptic vesicle protein 2A (SV2A), modulating neurotransmitter release and decreasing abnormal neuronal firing in seizures of various types. Levetiracetam is frequently used as first or add-on therapy in various age groups due to its wide efficacy range covering both focal and generalised seizures, as well as its favourable tolerability profile.Levipil Syrup is a type of levetiracetam available in liquid form. It is usually used in children who have difficulty swallowing tablets. Typically, children suffering from epilepsy syndromes which can be cured are often prescribed this syrup too. The syrup permits precise titration of dosage according to body weight, which is important to note, especially when it comes to children, as their dosage requirements change over time.
Levetiracetam is generally well tolerated but does carry a recognised behavioural side effect profile. The most commonly reported effects include:
Behavioural side effects are more common in patients with a pre-existing history of psychiatric conditions and should be monitored actively rather than attributed to other causes.
Regardless of the treatment approach, certain lifestyle habits consistently influence seizure threshold and the likelihood of achieving or maintaining remission:
Uncertainty about the prognosis of epilepsy brings about a distinctive kind of anxiety that is hard to understand by those unfamiliar with it. The families of children suffering from a condition expected to go into remission endure the anxiety connected with every doctor’s appointment and every seizure-free month. Adults coping with lifelong illnesses face different problems regarding their jobs, driving, relationships, and identity. Psychological assistance, specialised support groups, and clear communication with the treatment team all help with emotional adjustment in addition to clinical management.
The question of whether medication can be reduced or withdrawn is best addressed through a structured clinical review rather than a unilateral patient decision. Factors including the epilepsy syndrome, the seizure-free period achieved, EEG findings, and individual life circumstances all inform the decision about whether withdrawal is safe to attempt and at what pace.
The question of whether it is possible to heal epilepsy completely does not have the same answer for everyone. While in some cases epilepsy goes away, others learn to control it with medication, whereas for others, it becomes a serious issue that requires ongoing treatment. The best outcome for either the patient or their family is to get the diagnosis of the epilepsy syndrome with its future development prospects and to have a frank discussion with a specialist.
Disclaimer: This article is for general informational purposes only and should not be considered medical advice. Always consult a qualified neurologist or healthcare professional for diagnosis, treatment, and guidance specific to your condition.